Company · CIK 2022626
Upstream Bio, Inc.
| CIK | 2022626 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | UPB (Nasdaq) |
| First annual or quarterly report | 2024-11-07 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291267 | 2025-11-05 | 2026-03-26 | 2 | |
| 333-282197 | 2024-09-18 | 2024-10-11 | 4 |
Filings
7| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-26 | 424B5Shelf takedown | 333-291267 | 0001193125-26-126561 |
| 2025-11-05 | S-3ASRShelf registered | 333-291267 | 0001193125-25-265752 |
| 2024-10-11 | 424B4Final prospectus | 333-282197 | 0001193125-24-236714 |
| 2024-10-10 | EFFECTDeclared effective | 333-282197 | 9999999995-24-003150 |
| 2024-10-07 | S-1/AAmendment | 333-282197 | 0001193125-24-233296 |
| 2024-09-18 | S-1Registration filed | 333-282197 | 0001193125-24-221372 |
| 2024-06-12 | DRSDraft made public | 377-07271 | 0000950123-24-006208 |